A method based on isotonic regression estimation for identifying the maximum tolerated dose

MaRDI QIDQ5320124zbMATH OpenFDO

Authors Zhongzhan Zhang, Jian Tao, Xueli Wang, Ning-Zhong Shi

Publication date 22 July 2009

zbMATH Keywords

phase I clinical trialstoxicity-study

Mathematics Subject Classification ID

Applications of statistics to biology and medical sciences; meta analysis (62P10) Medical applications (general) (92C50) Sequential statistical design (62L05)

Recommendations

• scientific article; zbMATH DE number 2164064
• An assessment of up- and down designs and associated estimators in phase I trials
• Design and Analysis of Phase I Clinical Trials
• The treatment versus experimentation dilemma in dose finding studies
• A new look at evaluating MTD designs in cancer research

Cited in

(5)

• A new look at evaluating MTD designs in cancer research
• An assessment of up- and down designs and associated estimators in phase I trials
• Highest dose level for non-increased-toxicity response in longitudinal data
• scientific article; zbMATH DE number 2164064 (Why is no real title available?)
• The role of minimal sets in dose finding studies

This page was built for publication: A method based on isotonic regression estimation for identifying the maximum tolerated dose

Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q5320124)